. Author manuscript; available in PMC: 2017 Sep 6.

Published in final edited form as: Diab Vasc Dis Res. 2015 Jul 20;12(6):411–419. doi: 10.1177/1479164115592638

Table 3.

Association between baseline clinical characteristics and log adiponectin levels.^a

	All participants (N = 120)		Men (N = 84)		Women (N =36)

Variable	β	p	β	p	β	p
Age (years)	−0.01	0.02	−0.01	0.05	−0.01	0.25
Men	0.07	0.63	–	–	–	–
BMI (kg/m²)	0.001	0.90	<0.0001	0.93	0.002	0.92
History of diabetes	−0.001	0.10	0.25	0.24	−0.35	0.15
History of MI	−0.06	0.66	−0.03	0.85	−0.04	0.83
History of HF	−0.26	0.26	0.03	0.93	0.56	0.08
Hgb A1C (%)	0.02	0.69	0.06	0.41	−0.09	0.46
Log hs-CRP (mg/L)	0.08	0.47	0.14	0.34	−0.03	0.92
BNP (pg/mL)	−0.0003	0.80	−0.001	0.98	−0.0001	0.58

β: regression coefficient; BMI: body mass index; BNP: brain-type natriuretic peptide; hs-CRP: high-sensitivity C-reactive protein; Hgb A1C: glycosylated haemoglobin; HF: heart failure; MI: myocardial infarction.

First available adiponectin measurement for each participant was used in this analysis.